Skip to content

Keep On Keep Up for Parkinson's

Keep On Keep Up (KOKU4PD) - Developing an App for People With Parkinson's Disease

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06332794
Acronym
KOKU4PD
Enrollment
20
Registered
2024-03-27
Start date
2024-06-03
Completion date
2025-06-30
Last updated
2024-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Keywords

Exercise, Falls prevention, Technology, Physical activity, Co-design

Brief summary

The goal of this mixed methods, user research study is to evaluate the Keep On Keep Up programme for people with Parkinson's (KOKU4PD). The main aims of the study are to: 1. To explore the usability and acceptability of the PD specific KOKU programme from a user and health care professional perspective. 2. To produce a KOKU4PD digital program that is ready for National Health Service (NHS) approval and a future effectiveness evaluation. Participants will use the KOKU4PD app at home for 4 weeks. They will be assessed at baseline and after the 4 weeks to measure aspects of their disease status, mobility, thinking, mood and quality of life. They will also be asked to complete some questionnaires about the usability of the app.

Detailed description

Keep on Keep Up (KOKU) is a digital program available on a tablet that has been designed to engage people in safe and effective falls prevention exercises. KOKU incorporates evidence-based exercise programmes for balance and function and has demonstrated high usability and acceptability in older adults. KOKU is approved by NHS Digital as compliant with regulatory data and safety standards. Earlier work by the research team has shown that KOKU is effective in improving balance in older adults. However, the effectiveness of KOKU in PD is unknown. The purpose of this study is to explore if app-based exercise is feasible, acceptable and effective in PD, especially in harder-to-reach populations who may not exercise on a regular basis. Through mixed methods approaches, the proposed study aims to: (i) explore the usability and acceptability of the PD specific KOKU programme from a user and health care professional perspective and (ii) produce a KOKU4PD digital program that is ready for NHS approval and a future effectiveness evaluation. 20 people with PD will be recruited to take part in the study where they will be asked to use the KOKU app independently at home for 4 weeks. A repeated measure design will be employed with assessments performed at the clinical gait lab during two separate sessions lasting between 2-3 hours. Participants will attend the lab for outcomes to be measured at the start and after 4 weeks of exercise with the KOKU app. During the second lab visit, participants will complete a questionnaire about the usability of the KOKU app and take part in an interview to explore their experiences of using it.

Interventions

DEVICEKOKU4PD

Exercise at home using the KOKU app for 4 weeks.

Sponsors

University of Manchester
CollaboratorOTHER
Northumbria Healthcare NHS Foundation Trust
CollaboratorOTHER
Newcastle University
CollaboratorOTHER
Reason Digital
CollaboratorUNKNOWN
Northumbria University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Parkinson's by a movement disorder specialist according to United Kingdom (UK) brain bank criteria (H&Y stage I-III) * Able to walk and stand without support or assistance from another person * \>40 years * Stable medication for the previous 1 month and anticipated over a period of 6 months. * Adequate vision and hearing - to watch and use an iPad or Tablet.Aim: To define the study population/sample

Exclusion criteria

* Dementia (\<21 on Montreal Cognitive Assessment (MoCA) or as diagnosed according to the Movement Disorder Society guidelines * Orthopaedic or cardiothoracic ailments that preclude safe walking * Severe auditory or visual impairment, * Diagnosis of clinical depression

Design outcomes

Primary

MeasureTime frameDescription
Usability of the KOKU appAfter 4 weeks of using KOKU at homeParticipants will be asked to complete questionnaires about the usability of the KOKU app and participate in an interview based on their responses to the questionnaires.

Secondary

MeasureTime frameDescription
Trail Making Test (mean Change from baseline)After 4 weeks of using KOKU at homeTimed written test of visual function and scanning
Freezing of Gait Questionnaire (mean Change from baseline)After 4 weeks of using KOKU at homeSelf-report questionnaire
Falls Efficacy scale (mean Change from baseline)After 4 weeks of using KOKU at homeSelf-report questionnaire (minimum 16 (no concern about falling) to maximum 64 (severe concern about falling)
Parkinson's disease quality of life questionnaire - PDQ-39 (mean Change from baseline)After 4 weeks of using KOKU at homeThe 39 item questionnaire offers a patient reported measure of health status and quality of life. Items are grouped into eight scales that are scored by expressing summed item scores as a percentage score ranging between 0 and 100 (100 = more health problems).
Mini-BESTest (mean Change from baseline)After 4 weeks of using KOKU at homeThe Mini-BESTest is a clinical balance test that has shown a high sensitivity in detecting balance impairments in elderly people with Parkinson's disease. The Mini- BESTest consists of 14 items, with a maximum (best) score of 28 points.
Executive clock drawing task (CLOX 1, 2) (mean Change from baseline)After 4 weeks of using KOKU at homeA clock drawing task (CLOX) designed to elicit executive impairment and discriminate it from non-executive constructional failure.
EuroQol-5 Dimension Quality of Life tool - EQ5D-5L (mean Change from baseline)After 4 weeks of using KOKU at homeSelf-report quality fo life questionnaire - EQ-5D-5L index scores range from -0.59 to 1, where 1 is the best possible health state.
Activities-specific Balance Confidence (ABC) Scale (mean Change from baseline)After 4 weeks of using KOKU at homeThe Activities-specific Balance confidence (ABS) scale is a questionnaire developed to assess older individual's balance confidence in performing daily activities. There are 16 items, representing daily activities. Participants are asked to answer, with a score from 0% (not confident at all) to 100% (completely confident) in increments of 10%, how confident they are in performing each activity. The average score obtained is an indication on balance confidence. A score of \> 80% indicates high level of functioning. A score of 50%-80% indicates moderate level of functioning. A score of \< 50% indicates low levels of functioning. Additionally, a score of \< 67% suggests substantial risk of falling.
Multidimensional Fatigue Inventory (MFI) (mean Change from baseline)After 4 weeks of using KOKU at homeThe MFI is a 20-item inventory scored on a 5-point Likert scale and measures five dimensions of fatigue: general fatigue, physical fatigue, mental fatigue, reduced motivation, and reduced activity. The MFI dimension scores range from 4 to 20 (most severe) and have been credited with reliably measuring fatigue severity in each dimension.
Technology Acceptance questionnaireAfter 4 weeks of using KOKU at homeSelf-report questionnaire, based on the Technology Acceptance Model. There are 15 items which participants have to rate on a scale of 1 (= strongly disagree) to 7 (strongly agree).
Two minute walk test, single and dual task (mean Change from baseline)After 4 weeks of using KOKU at homeParticipant walks continually for 2 minutes; for dual task, participant is asked to recall numbers as they are walking

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026